Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 3 D003876 ClinicalTrials
Neonatal Sepsis 3 D000071074 ClinicalTrials
Irritable Bowel Syndrome 3 D043183 ClinicalTrials
Constipation 3 D003248 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Colitis, Ulcerative 2 D003093 ClinicalTrials
Insulin Resistance 2 D007333 ClinicalTrials
Diarrhea 2 D003967 ClinicalTrials
Sepsis 2 D018805 ClinicalTrials
Parkinson Disease 2 D010300 ClinicalTrials
Sarcopenia 2 D055948 ClinicalTrials
Central Serous Chorioretinopathy 2 D056833 ClinicalTrials
Digestive System Diseases 2 D004066 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials
Infections 2 D007239 ClinicalTrials
Rotavirus Infections 2 D012400 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Heart Failure 1 D006333 ClinicalTrials
Metabolic Syndrome 1 D024821 ClinicalTrials
Pouchitis 1 D019449 ClinicalTrials
Graft vs Host Disease 1 D006086 ClinicalTrials
Autistic Disorder 1 D001321 ClinicalTrials
Prediabetic State 1 D011236 ClinicalTrials
Aging 0 D000375 ClinicalTrials
Diabetes Mellitus 0 D003920 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 9050-36-6
ChEMBL CHEMBL2107951
FDA SRS 7CVR7L4A2D